Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Oncolytics Biotech, Inc. Common Shares (ONCY)

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/05/2001

Market Cap

73,598,616

Shares Outstanding

73,400,000

Weighted SO

73,398,847

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

SCPH --.--%

MIST --.--%

MCRB --.--%

LIFE --.--%

DMAC --.--%

IKT --.--%

XFOR --.--%

GRTX --.--%

Beta

1.3970

Last Div

0.0000

Range

0.85-2.49

Chg

-0.0141

Avg Vol

187770

Mkt Cap

73598616

Exch

NASDAQ

Country

CA

Phone

14036707380

DCF Diff

0.5996

DCF

0.3352

Div Yield

0.0000

P/S

0.0000

EV Multiple

-2.1547

P/FV

5.4390

Div Yield %

0.0000

P/E

-3.5539

PEG

-0.7641

Payout

0.0000

Current Ratio

4.9915

Quick Ratio

4.9915

Cash Ratio

3.6329

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

750.3248

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0081

ROA

-0.8739

ROE

-1.1455

ROCE

-1.4092

NI/EBT

1.0052

EBT/EBIT

0.7629

EBIT/Rev

0.0000

Debt Ratio

0.0348

D/E

0.0609

LT Debt/Cap

0.0464

Total Debt/Cap

0.0574

Int Coverage

0.0000

CF/Debt

-23.6935

Equity Multi

1.7514

Rec Turnover

0.0000

Pay Turnover

0.4865

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.3475

FCF/Share

-0.3502

Cash/Share

0.3266

OCF/Sales

0.0000

FCF/OCF

1.0077

CF Coverage

-23.6935

ST Coverage

-117.5200

CapEx Coverage

-129.6176

Div&CapEx Cov

-129.6176

P/BV

5.4390

P/B

5.4390

P/S

0.0000

P/E

-3.5539

P/FCF

-3.7816

P/OCF

-3.7665

P/CF

-3.7665

PEG

-0.7641

P/S

0.0000

EV Multiple

-2.1547

P/FV

5.4390

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation